Nintedanib versus placebo in patients receiving mFOLFOX6 for metastatic, chemorefractory colorectal cancer: TRICC-C trial—Final results from the randomized phase II trial of the AIO. This is an ASCO ...
Utility of a Clinically Guided Data-Driven Approach for Predicting Breast Cancer Complications: An Application Using a Population-Based Claims Data Set Performing a geriatric assessment as part of ...
Please provide your email address to receive an email when new articles are posted on . In my more than 30-year career as a registered dietitian in gastroenterology, it has been exciting to see the ...
COVID-19 patients show a 37% higher risk of developing new gastrointestinal disorders compared to COVID-19-negative individuals. The study analyzed data from over 1.1 million patients, with 56,745 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback